The role of LH receptor in human IVF-ET program

Synthetic Glycopeptide-Based Vaccines

“…One approach relies on the construction of a polyantigenic vaccine from the admixture of several existing monoantigenic conjugate vaccines, in either clustered or non-clustered form [31,89]. This idea has been used extensively in fields outside of cancer (e.g., bacterial vaccines) [90,91]. Preclinical trials using polymolecular glycoconjugates have demonstrated the viability of this method.…”